Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-642
Closed -$222K 422
2021
Q2
$222K Buy
+642
New +$194K 0.02% 405
2020
Q1
Sell
-1,194
Closed -$354K 352
2019
Q4
$354K Sell
1,194
-1,368
-53% -$380K 0.06% 251
2019
Q3
$596K Buy
2,562
+760
+42% +$177K 0.12% 152
2019
Q2
$421K Buy
+1,802
New +$416K 0.1% 180

Other funds holding BIIB

RFG Advisory's BIIB Position: Q3 2021 in Review

RFG Advisory sold out of Biogen (BIIB) in Q3 2021, closing a stake of 642 shares — an estimated $222K sold.

RFG Advisory first reported a position in BIIB in Q2 2019 and held it in 4 quarters. The position peaked at $596K in Q3 2019. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • RFG Advisory reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • RFG Advisory sold 642 Biogen shares in Q3 2021, an estimated $222K.
  • RFG Advisory first reported a position in Biogen in Q2 2019 and held it in 4 quarters.
  • RFG Advisory's Biogen position peaked at $596K in Q3 2019.
  • 1,041 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on RFG Advisory's 13F filing for Q3 2021, filed 19 Oct 2021.